New On Demand Dr. Nick: The Incrementalist: With guest Zachary Green, a U.S. Marine Corps veteran and former Firefighter, author of ‘Warrior Entrepreneur’ book who has had an interesting career and some major events and adversity that he has had to overcome.
Read More
Value-Based Care Insights Podcast with host Daniel J. Marino. In this episode Dan speaks with John Malone to highlight the extent of the COVID-19 impact and example solutions that work to address workforce challenges.
New On Demand Healthcare Upside/Down with guest Greg Bellomy, CEO of Care ATC. He joins Dr. Nick to discuss why shooting for the moon in healthcare starts with going back to basics.
New On Demand Dr. Nick: The Incrementalist: With guest Jennifer Meller, MD, CEO & Founder of Navimize, that is focusing on solving the problem of dissatisfaction for patients stuck in waiting rooms around the country.
The Tate Chronicles episode now on demand. A conversation on patient engagement technologies with Vik Krishnan, General Manager at Intrado and host Jim Tate.
New On Demand Healthcare Upside/Down: With guest Pramod John, CEO of Vivio Health. He joins Dr. Nick to discuss why we need to ask the right questions about our healthcare system, rethink many of our assumptions, and examine the ways that economic incentives influence care decisions.
New On Demand Dr. Nick: The Incrementalist: With guests Morgane Mouslim, PhD a Policy analyst at the Hilltop Institute at the University of Maryland Baltimore County and Morgan Henderson, PhD, a Data Scientist at the Hilltop Institute at the University of Maryland Baltimore County.
February is all about matters of the heart. Don’t forget your Valentine and do your part to learn more and spread awareness about American Heart Month. Do you know what the symptoms of heart attack, stroke and cardiac arrest look like?
New On Demand Healthcare Upside/Down: With guest AJ Loiacono, CEO of CapitalRx, an organization dedicated to disrupting the pharmacy benefit manager marketplace. He joins Dr. Nick to discuss the reasons why drug prices are so exorbitant—and he’s hopeful that change is on the horizon.